Savara Pharma Closes Series A Round
Savara Pharmaceuticals, an Austin, Texas-based developer of inhalation drug delivery solutions, has closed its Series A round in excess of its $1.4 million target. No investor information was disclosed.
16 December 2009•2 mins read
